Humanigen Inc (HGENQ)

[cowtown jay]

Baudax's corporate controller, Jillian Dilmore, has resigned. I was a funds administrator in the Army, but Jillian has scary-skills dealing with merger subs, etc., and her Deloitte & Touche background was evident. I felt more comfortable reading clinical trial data, than trying to understand what Jillian was doing. She was impressive.

https://www.sec.gov/ix?doc=/Archives/edgar/data/1780097/000119312523251966/d416304d8k.htm

But also impressive is how this whole restructuring is taking place in the pre-Q3 filing period. I can understand holding up the second quarter 10-Q in preparation of a stock play, executed from the Pink Limited trading venue. I saw both Gracell and Baudax submitted Registration Statements, and how those became effective on the same day. But how Humanigen, Gracell, and Baudax (and Novavax or PCI Pharma?) are going to fit together, as I think they somehow will, is an orchestration I look forward to watching. I note that at this point, neither Baudax nor Humanigen have a Chief Financial Officer, and I wonder if Kevin Xie will assume those functions.